News Snapshot:
Health officials in South Korea on Wednesday approved the country’s first domestically developed Covid-19 vaccine for people 18 years or older, adding another public health tool in the fight against a prolonged pandemic. In clinical trials involving some 4,000 participants in South Korea and five other countries, SK Bioscience’s two-dose SKYCovione vaccine appeared to be more effective than the broadly used AstraZeneca shots in building immunity against infections, officials at South Korea’s Food and Drug Safety Ministry said. It isn’t immediately clear how officials will administer the newly developed vaccine or how big of a role the shots will have...
